Contact us
Young GI
Patients
Industry
Press
My Connect
Create myUEG account
About
To landing page
Who we are
Boards, Committees & Groups
Governance
Headquarters Management
History
What we do
Strategic Drivers
Year in Review
Our Members
Specialist Member Societies
National Member Societies
myUEG Community
myUEG Associates
My Connect
Women in GI
Young GIs
Researchers
Event Calendar
Week
To landing page
Attendance
Registration fees
Hotel
Venue
Helpful info
Travel info
Programme
Abstract Submission
Postgraduate Teaching
Nurse Programme
Hands-on
Information for Presenters
In-person Networking
myUEG Community Area
Learn from Leaders
Mentoring
The UEG Night
Let's Meet
Women in GI Networking
Industry Programme
Industry Exhibition
Industry Symposia
Meet the experts sessions
Innovation Hub
List of Supporters & Exhibitors
CME Accreditation
UEG Week on-demand
Future UEG Weeks
Education
To landing page
Online Education
Online Courses
Webinars
Career Development
Face-to-face Education
Summer School
Masterclass
Clinical Visiting Fellowships
Education Resources
Mistakes in...
UEG Talks Podcast
Image Hub
CME in Europe
Event Endorsement
Supporters
Research
To landing page
Support
Horizon Europe Support
Start-up Grant
Research Prize
Research Fellowship
Research Webinars
Research Projects
HoloSurge
Position Papers
White Book 2
Main Results
Full Reports
Materials and Presentations
Quality of Care
To landing page
Search Guidelines
Standards & Guidelines Repository
Non-English Guidelines
GI Guidelines App
Develop & Implement
How to develop guidelines
Guideline Endorsement
Guideline Webinars
Projects
Quality of Care Initiatives
Quality Standards
Public Affairs
To landing page
Advocacy
Core Positions
Stakeholder Collaboration
White Book 2
Position Papers
MEP Digestive Health Group
Our Supporters
#EUNewsline →
EU Elections 2024
Publications
To landing page
Publications
Congress Publications
Research Publications
Public Affairs Publications
Education Publications
UEG Publications
UEG Journal →
UEG Journal Podcast
White Book 2
Opportunities
To landing page
Congress Opportunities
Top Abstract Prizes
National Scholar Award
Travel Grants
International Scholarship Awards
Research Funding
Research Prize
Research Fellowship
Horizon Europe Support
Start-up Grant
Activities Funding
Recognition of Achievements
Lifetime Achievement Award
Journal Best Paper Award
Activities Endorsement
Professional Advancement
Rising Star Awards
Clinical Visiting Fellowships
Open Positions
Talent Pool
Library
To landing page
Congress Resources
UEG Week on-demand
Abstracts
Posters
Guideline Resources
Education Resources
Image Hub
Webinars
Mistakes in... articles
Contact us
Young GI
Patients
Industry
Press
Session
IBD (Posters)
THE INCREMENTAL RATE OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE COMPARED TO PATIENTS WITHOUT IMMUNE-MEDIATED DISEASES
IBD (Posters)
et al.
NOVEL SERUM SOLUBLE MARKERS OF HISTOLOGICAL HEALING IN ULCERATIVE COLITIS
IBD (Posters)
et al.
DEGREE OF HISTOLOGICAL ACTIVITY IS NOT ASSOCIATED WITH VEDOLIZUMAB THERAPY OUTCOME IN ULCERATIVE COLITIS
IBD (Posters)
et al.
EFFICACY AND SECURITY OF USTEKINUMAB: OUR EXPERIENCE
IBD (Posters)
et al.
EVALUATION OF SYMPTOM IMPROVEMENT DURING INDUCTION IN PATIENTS WITH CROHN'S DISEASE TREATED WITH MIRIKIZUMAB
IBD (Posters)
et al.
ANTI-DRUG ANTIBODIES DETECTED IN THE PRESENCE OF ADEQUATE INFLIXIMAB DRUG LEVELS IN IBD PATIENTS IN CLINICAL REMISSION HAVE LIMITED CLINICAL SIGNIFICANCE
IBD (Posters)
et al.
INVESTIGATING THE ASSOCIATIONS BETWEEN PATIENT REPORTED OUTCOMES AND FAECAL CALPROTECTIN IN ULCERATIVE COLITIS: THE DISCORDANCE BETWEEN 'GUT FEELING' AND IBD -'CONTROL'
IBD (Posters)
et al.
COST EFFECTIVENESS OF A PROACTIVE THERAPEUTIC DRUG MONITORING STRATEGY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE RECEIVING INFLIXIMAB
IBD (Posters)
et al.
IMMUNOSUPPRESSANT MAINTENANCE THERAPY IN INFLAMMATORY BOWEL DISEASE: A REVIEW OF SERIOUS ADVERSE EVENTS
IBD (Posters)
et al.
ABSENCE OF BOWEL URGENCY IS ASSOCIATED WITH IMPROVEMENTS IN CLINICAL OUTCOMES IN PATIENTS WITH ULCERATIVE COLITIS RECEIVING MIRIKIZUMAB
IBD (Posters)
et al.
EVALUATION OF CLINICAL RELATIONSHIP BETWEEN FECAL CALPROTECTIN AND ENDOSCOPIC FINDINGS IN ULCERATIVE COLITIS PATIENTS TREATED WITH INFLIXIMAB (CT-P13) SUBCUTANEOUS AND INTRAVENOUS THERAPY: RESULTS FROM A MULTICENTER, RANDOMIZED, CONTROLLED PIVOTAL TRIAL
IBD (Posters)
et al.
SUBOPTIMAL VACCINATION ADHERENCE IN MOTHERS WITH INFLAMMATORY BOWEL DISEASE AND THEIR BIOLOGIC EXPOSED INFANTS
IBD (Posters)
et al.
ANXIETY, DEPRESSION AND ALEXITHYMIC TRAITS IN INFLAMMATORY BOWEL DISEASE (IBD) PATIENTS: CORRELATIONS WITH CLINICAL SYMPTOMS AND INFLAMMATION INDICES
IBD (Posters)
et al.
CROHN'S DISEASE EXCLUSION DIET INDUCES REMISSION IN ADULTS WITH MILD TO MODERATE CROHN´S DISEASE: PRELIMINARY REPORT FROM A RANDOMISED CONTROLLED TRIAL (CDED-AD TRIAL)
IBD (Posters)
et al.
THE PRESENCE OF CITRATE IN ADALIMUMAB-BASED TREATMENTS CORRELATES WITH THE PERCEPTION OF PAIN AFTER SUBCUTANEOUS INJECTION, IN INFLAMMATORY BOWEL DISEASE PATIENTS
IBD (Posters)
et al.
BIOMARKERS OF EXTRACELLULAR MATRIX REMODELLING ARE ASSOCIATED WITH INTESTINAL FIBROSIS ASSESSED BY MAGNETIC RESONANCE ENTEROGRAPHY AND ACCUMULATED INTESTINAL DAMAGE (LÉMANN INDEX) - THE IBSEN STUDY
IBD (Posters)
et al.
ROLE OF IFN?-ACTIVATED MACROPHAGES IN THE EPITHELIAL MESENCHYMAL TRANSITION IN CROHN'S DISEASE
IBD (Posters)
et al.
BIOMARKERS OF ELASTIN DEGRADATION IS ASSOCIATED WITH CLINICAL AND BIOCHEMICALLY ACTIVE DISEASE IN CROHN'S DISEASE
IBD (Posters)
et al.
PHYSICAL EXERCISE IS ASSOCIATED WITH BETTER BODY COMPOSITION TRAITS IN YOUNG ADULTS WITH CHILDHOOD-ONSET INFLAMMATORY BOWEL DISEASE
IBD (Posters)
et al.
RAC1/PSTAT3 EXPRESSION IN LYMPHOCYTES MAY SERVE AS A PHARMACODYNAMIC MARKER TO OPTIMIZE PERSONALIZED THIOPURINE THERAPY IN IBD PATIENTS
IBD (Posters)
et al.
Item 121 - 140 / 279
1
2
3
4
5
6
7
8
9
10
11
12
13
14
Chat with us
, powered by
LiveChat